These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18054515)

  • 1. Cytokines, dendritic cells and immunological rejection.
    Ferrantini M; Belardelli F
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):1-2. PubMed ID: 18054515
    [No Abstract]   [Full Text] [Related]  

  • 2. [To stay immature: the first step to tolerate?].
    Grosjean F
    G Ital Nefrol; 2008; 25(4):383. PubMed ID: 18663680
    [No Abstract]   [Full Text] [Related]  

  • 3. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity.
    Rubic T; Lametschwandtner G; Jost S; Hinteregger S; Kund J; Carballido-Perrig N; Schwärzler C; Junt T; Voshol H; Meingassner JG; Mao X; Werner G; Rot A; Carballido JM
    Nat Immunol; 2008 Nov; 9(11):1261-9. PubMed ID: 18820681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in vivo: a key target for a new vaccine science.
    Steinman RM
    Immunity; 2008 Sep; 29(3):319-24. PubMed ID: 18799140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
    Wadia PP; Tambur AR
    Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "To B or not to B?" B-cells and graft rejection.
    Zarkhin V; Li L; Sarwal M
    Transplantation; 2008 Jun; 85(12):1705-14. PubMed ID: 18580460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instability of cytokines at body temperature.
    Suga M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2005 Apr; 24(4):504-5. PubMed ID: 15797758
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology and diagnosis of acute rejection.
    Häyry P
    Transplant Proc; 1999 Jun; 31(4):1789. PubMed ID: 10371953
    [No Abstract]   [Full Text] [Related]  

  • 11. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Networks in Transplant Rejection. Preface.
    Zeevi A; Webber SA
    Clin Lab Med; 2008 Sep; 28(3):xi-xiii. PubMed ID: 19028256
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
    Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
    Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
    Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
    Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans.
    Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ
    J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
    Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
    Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.
    Hashimoto-Okada M; Kitawaki T; Kadowaki N; Iwata S; Morimoto C; Hori T; Uchiyama T
    Int Immunol; 2009 Aug; 21(8):891-904. PubMed ID: 19556308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.